Your browser doesn't support javascript.
loading
Guideline on treating community-acquired pneumonia with Chinese patent medicines.
Wang, Minghang; Liu, Huiguo; Chen, Yaolong; Yu, Jiajie; Lin, Jiangtao; Sun, Zengtao; Li, Jiansheng; Bai, Gang; Wen, Fuqiang; Xie, Yang; Wang, Jianxin; Yang, Jiang; Li, Suyun.
Afiliación
  • Wang M; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China.
  • Liu H; Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
  • Chen Y; China Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730030, China; Chinese GRADE Center, Lanzhou, China.
  • Yu J; Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610000, China; The Chinese Cochrane Center, Chengdu, China.
  • Lin J; China-Japan Friendship Hospital, Beijing, China.
  • Sun Z; The Second Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin, China.
  • Li J; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China.
  • Bai G; Nankai University, Tianjin 300193, China.
  • Wen F; Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610000, China; The Chinese Cochrane Center, Chengdu, China.
  • Xie Y; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China.
  • Wang J; Standardization Project Management Office of China Association of Traditional Chinese Medicine, Beijing 100061, China.
  • Yang J; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China.
  • Li S; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou 450000, China. Electronic address: lisuyun2
Pharmacol Res ; 196: 106919, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37722517
Community-acquired pneumonia (CAP) is one of the most common infectious diseases, and its morbidity and mortality increase with age. Resistance and mutations development make the use of anti-infective therapy challenging. Chinese patent medicines (CPMs) are often used to treat CAP in China and well tolerable. However, currently there are no evidence-based guideline for the treatment of CAP with CPMs, and the misuse of CPMs is common. Therefore, we established a guideline panel to develop this guideline. We identified six clinical questions through two rounds of survey, and we then systematically searched relevant evidence and performed meta-analyses, evidence summaries and GRADE decision tables to draft recommendations, which were then voted on by a consensus panel using the Delphi method. Finally, we developed ten recommendations based on evidence synthesis and expert consensus. For the treatment of severe CAP in adults, we recommend Tanreqing injection, Reduning injection, Xuebijing injection, Shenfu injection, and Shenmai injection respectively. For the treatment of non-severe CAP in adults, we recommend Tanreqing injection, Reduning injection, Lianhua Qingwen capsule/granule, Qingfei Xiaoyan Pill and Shufeng Jiedu capsule respectively. CPMs have great potential to help in the fight against CAP worldwide, but more high-quality studies are still needed to strengthen the evidence.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos